Clinicopathological features of radiological early malignant pleural mesothelioma with no apparent tumor or pleural thickening
- 1 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Clinical Oncology
- Vol. 26 (1), 95-103
- https://doi.org/10.1007/s10147-020-01780-0
Abstract
Background We occasionally encounter malignant pleural mesothelioma (MPM) of no apparent tumor or pleural thickening that is radiological early MPM. This study aimed to examine the clinicopathological outcomes of radiological early MPM. Methods Patients with MPM treated with neoadjuvant chemotherapy and planned surgery at the time of diagnosis between July 2004 and December 2019 were retrospectively examined. Pretreatment maximal pleural thickness of all patients was measured on chest computed tomography. We extracted and investigated the patients who exhibited a lack of pleural thickening or visible tumor, which was defined as radiological early MPM. Survival was analyzed by the Kaplan-Meier method. Results Of 296treated patients, 16 (5.4%) exhibited radiological early MPM. Fourteen (87.5%) of these patients underwent pleurectomy/decortication and 2 (12.5%) underwent extrapleural pneumonectomy. Pathological stage T1 disease was diagnosed in 14 (87.5%) patients; 2 (12.5%) exhibited pulmonary parenchymal invasion (pathological stage T2). Lymphatic invasion was detected in only 1 patient. Lymph node metastases and vascular invasion were not detected. Median follow-up was 42 months. Median progression-free survival and median overall survival were 40.7 and 56.1 months, respectively. The 3-year progression-free survival and overall survival rates were 84.8% and 83.6%, respectively. Conclusions Radiological early MPM occurs in approximately 1 of every 20 patients treated with neoadjuvant chemotherapy and surgery planned at the time of diagnosis in an experienced center. Radiological early MPM was associated with early pathological stage and long-term survival.Keywords
This publication has 19 references indexed in Scilit:
- Preoperative prediction of unresectability in malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 2020
- Clinical Outcomes With Recurrence After Pleurectomy/Decortication for Malignant Pleural MesotheliomaThe Annals of Thoracic Surgery, 2020
- Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural MesotheliomaSeminars in Thoracic and Cardiovascular Surgery, 2019
- Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 2018
- The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for MesotheliomaJournal of Thoracic Oncology, 2016
- The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural MesotheliomaJournal of Thoracic Oncology, 2016
- Updated patterns of failure after multimodality therapy for malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 2015
- Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomyInternational Journal of Clinical Oncology, 2012
- Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patientsThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Modified RECIST criteria for assessment of response in malignant pleural mesotheliomaAnnals of Oncology, 2004